Skip to content
10-Q

Quarterly Report

ENvue Medical, Inc. FEED

0001641172-25-024854

← back to feed
Filed
Aug 19, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 19, 2025 796.95K sh
Shares Diluted Q2 2025 · Jun 30, 2025 484.57K sh
Shares Diluted Q2 2025 · Jun 30, 2025 268.39K sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 25.31K sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 24.07K sh
Capex Q2 2025 · Jun 30, 2025 $9K
Capex Q2 2025 · Jun 30, 2024 $3K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$4.73M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$1.13M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $4.03M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $752K
Stockholders Equity Q2 2025 · Jun 30, 2025 $40.48M
Stockholders Equity Q2 2025 · Mar 31, 2025 $35.68M
Stockholders Equity Q2 2025 · Dec 31, 2024 $627K
Stockholders Equity Q2 2025 · Jun 30, 2024 $2.84M
Stockholders Equity Q2 2025 · Mar 31, 2024 $3.5M
Stockholders Equity Q2 2025 · Dec 31, 2023 $3.99M
Current Liabilities Q2 2025 · Jun 30, 2025 $6.54M
Current Liabilities Q2 2025 · Dec 31, 2024 $2.72M
Total Liabilities Q2 2025 · Jun 30, 2025 $11.01M
Total Liabilities Q2 2025 · Dec 31, 2024 $3M
Current Assets Q2 2025 · Jun 30, 2025 $6.89M
Current Assets Q2 2025 · Dec 31, 2024 $3.33M
Total Assets Q2 2025 · Jun 30, 2025 $51.48M
Total Assets Q2 2025 · Dec 31, 2024 $3.63M
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.03
Eps Diluted Q2 2025 · Jun 30, 2025 −$8.84
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$27.18
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$53.00
Eps Basic Q2 2025 · Jun 30, 2025 −$1.03
Eps Basic Q2 2025 · Jun 30, 2025 −$8.84
Eps Basic restated Q2 2025 · Jun 30, 2024 −$27.18
Eps Basic restated Q2 2025 · Jun 30, 2024 −$53.00
Sga Expense Q2 2025 · Jun 30, 2025 $2.25M
Sga Expense Q2 2025 · Jun 30, 2025 $3.59M
Sga Expense Q2 2025 · Jun 30, 2024 $716K
Sga Expense Q2 2025 · Jun 30, 2024 $1.66M
Rd Expense Q2 2025 · Jun 30, 2025 $972K
Rd Expense Q2 2025 · Jun 30, 2025 $1.5M
Rd Expense Q2 2025 · Jun 30, 2024 $187K
Rd Expense Q2 2025 · Jun 30, 2024 $308K
Net Income Q2 2025 · Jun 30, 2025 −$3.97M
Net Income Q2 2025 · Jun 30, 2025 −$5.84M
Net Income Q2 2025 · Jun 30, 2024 −$688K
Net Income Q2 2025 · Jun 30, 2024 −$1.28M
Operating Income Q2 2025 · Jun 30, 2025 −$3.98M
Operating Income Q2 2025 · Jun 30, 2025 −$5.83M
Operating Income Q2 2025 · Jun 30, 2024 −$674K
Operating Income Q2 2025 · Jun 30, 2024 −$1.24M
Gross Profit Q2 2025 · Jun 30, 2025 −$35K
Gross Profit Q2 2025 · Jun 30, 2025 $334K
Gross Profit Q2 2025 · Jun 30, 2024 $428K
Gross Profit Q2 2025 · Jun 30, 2024 $1.09M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $529K
Cost Of Revenue Q2 2025 · Jun 30, 2025 $1.19M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $389K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $646K
Revenue Q2 2025 · Jun 30, 2025 $494K
Revenue Q2 2025 · Jun 30, 2025 $1.52M
Revenue Q2 2025 · Jun 30, 2024 $817K
Revenue Q2 2025 · Jun 30, 2024 $1.74M